NoticeThis is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
LRBA deficiency due homozygous nonsense mutations. It is a rare
genetic disorder of the immune system caused by mutation in LRBA
gene. This disease results in excessive number of immune cells calls
lymphocytes ,autoimmunity, low levels of antibodies and recurrent
infections. Excess of lymphocytes caused a variety of symptoms, the
infiltration is most commun in the gut, lungs, and brain. LRBA deficiency
(called LATAIE disease) may increase a person's risk of lymphoma, a
type of cancer.
1 total trials
Filter these 1 trials by phase, country, sponsor and more.